Anti-angiogenic therapies in brain metastases
暂无分享,去创建一个
[1] S. McGovern,et al. Bevacizumab as an effective treatment for radiation necrosis after radiotherapy for melanoma brain metastases , 2017, Melanoma research.
[2] F. Bonnetain,et al. Bevacizumab in Combination with Platinum-Based Chemotherapy in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with or without Brain Metastases: A French Cohort Study (EOLE) , 2017, Oncology.
[3] P. Lockman,et al. Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden , 2017, Front. Pharmacol..
[4] M. Fabrini,et al. Bevacizumab for the Treatment of Radiation-Induced Cerebral Necrosis: A Systematic Review of the Literature , 2017, Journal of clinical medicine research.
[5] Alexander Radbruch,et al. Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO) , 2017, Neuro-oncology.
[6] A. Ardavanis,et al. Bevacizumab, pemetrexed and carboplatin in first-line treatment of non-small cell lung cancer patients: Focus on patients with brain metastases. , 2016, Oncology letters.
[7] S. Lim,et al. Palliative Resection of Metastatic Brain Tumors Previously Treated by Stereotactic Radiosurgery , 2016, Brain tumor research and treatment.
[8] J. Hainfellner,et al. Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers , 2016, ESMO Open.
[9] J. Trojan,et al. Bevacizumab in Combination with Chemotherapy for Colorectal Brain Metastasis , 2016, Journal of Gastrointestinal Cancer.
[10] W. Wick,et al. Bevacizumab Prevents Brain Metastases Formation in Lung Adenocarcinoma , 2016, Molecular Cancer Therapeutics.
[11] T. Mikkelsen,et al. Phase II trial of sunitinib as adjuvant therapy after stereotactic radiosurgery in patients with 1–3 newly diagnosed brain metastases , 2015, Journal of Neuro-Oncology.
[12] J. Pichler,et al. Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases , 2015, Neuropathology and applied neurobiology.
[13] J. Soria,et al. Bevacizumab in Patients with Nonsquamous Non–Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study , 2015, Clinical Cancer Research.
[14] L. Gras,et al. REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[15] M. Preusser,et al. Alleviation of Brain Edema and Restoration of Functional Independence by Bevacizumab in Brain-Metastatic Breast Cancer: A Case Report , 2014, Breast Care.
[16] A. Ravaud,et al. A phase II trial of sunitinib in patients with renal cell cancer and untreated brain metastases. , 2014, Clinical genitourinary cancer.
[17] Frank Winkler,et al. Invasion patterns in brain metastases of solid cancers. , 2013, Neuro-oncology.
[18] J. Villano,et al. Bevacizumab and central nervous system (CNS) hemorrhage , 2013, Cancer Chemotherapy and Pharmacology.
[19] L. Zini,et al. Do anti-angiogenic therapies prevent brain metastases in advanced renal cell carcinoma? , 2012, Bulletin du cancer.
[20] D. Schadendorf,et al. Trial design on prophylaxis and treatment of brain metastases: lessons learned from the EORTC Brain Metastases Strategic Meeting 2012. , 2012, European journal of cancer.
[21] C. Porta,et al. Sunitinib in metastatic renal cell carcinoma patients with brain metastases , 2011, Cancer.
[22] T. Mikkelsen,et al. Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study. , 2010, The oncologist.
[23] B. Besse,et al. Bevacizumab Safety in Patients with Central Nervous System Metastases , 2009, Clinical Cancer Research.
[24] M. Socinski,et al. Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] Sana Intidhar Labidi,et al. Bevacizumab and paclitaxel for breast cancer patients with central nervous system metastases: a case series. , 2009, Clinical breast cancer.
[26] J. Posner,et al. Brain metastases: epidemiology and pathophysiology , 2005, Journal of Neuro-Oncology.
[27] Jill S Barnholtz-Sloan,et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] Jochen Herms,et al. Real-time imaging reveals the single steps of brain metastasis formation , 2010, Nature Medicine.